ShareHope Medicine Co (ROCO:8403) Current Deferred Revenue: NT$0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8403 ShareHope Medicine Co Ltd ROCO:8403
72 GF Score
Price NT$19.10
GF Value NT$28.96
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is ShareHope Medicine Co Current Deferred Revenue?

ShareHope Medicine Co ROCO:8403 +0.26% 72 Current Deferred Revenue is NT$0 Mil as of Jun. 2026. GuruFocus rates ROCO:8403 with a GF Score™ of 72/100 and a GF Value™ of NT$28.96 (Possible Value Trap). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

ShareHope Medicine Co's current deferred revenue for the quarter that ended in Jun. 2026 was NT$0 Mil.

ShareHope Medicine Co Current Deferred Revenue Related Terms

ShareHope Medicine Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for ShareHope Medicine Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ShareHope Medicine Co Current Deferred Revenue Chart

ShareHope Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ShareHope Medicine Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:8403
72GF Score
ShareHope Medicine Co Ltd ROCO:8403
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of NT$0 Mil mean?
ShareHope Medicine Co (ROCO:8403) has a Current Deferred Revenue of NT$0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on ShareHope Medicine Co and its competitors.
Is ShareHope Medicine Co's Current Deferred Revenue too high?
ShareHope Medicine Co's current Current Deferred Revenue is NT$0 Mil. Overall, ShareHope Medicine Co has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's Current Deferred Revenue compare to MCK and COR?
ShareHope Medicine Co's Current Deferred Revenue of NT$0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Distribution company?
A good Current Deferred Revenue depends on the Medical Distribution industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on ShareHope Medicine Co and its competitors. ShareHope Medicine Co's current Current Deferred Revenue is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$28.96, compared to a current price of NT$19.10 — trading 34% below its estimated fair value. The current Current Deferred Revenue is NT$0 Mil. ShareHope Medicine Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current Current Deferred Revenue is NT$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?

Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued. The current stock price of NT$19.10 is trading 34% below its estimated GF Value™ of NT$28.96. GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.

Key valuation signals for ROCO:8403:

  • Current Deferred Revenue: NT$0 Mil
  • GF Value™: NT$28.96 vs. price of NT$19.10 (34% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ShareHope Medicine Co Business Description

Address No.168 Jingguo Road, 19th Floor, Taoyuan District, Taoyuan, TWN
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
72GF Score

Get the complete analysis for ROCO:8403

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$19.10
Price
NT$28.96
GF Value